
Risk-of-bias assessment using Cochrane's revised tool for randomized trials (RoB 2) was useful but challenging and resource-intensive: observations from a systematic review
Medicina e TecnologiaResumo original em inglês
O que aconteceu
To report our experience using version 2 of the Cochrane risk-of-bias tool for randomized trials (RoB 2).
Two reviewers independently applied RoB 2 to results of interest in a large systematic review of complex interventions and reached consensus. We recorded the time taken, and noted and discussed our difficulties using the tool, and the resolutions we adopted. We explored the time taken with regression analysis and summarized our experience of implementing the tool.
O que encontraram
We assessed risk of bias in 860 results of interest in 113 studies. Staff resource averaged 358 minutes per study (SD 183). Number of results (β = 22) and reports (β = 14) per study and experience of the team (β = -6) significantly affected assessment time. To implement the tool consistently, we developed cut points for missingness and considerations of balance regarding missingness, assumed some concerns with intervention deviations unless otherwise prevented or investigated, some concerns with measurements from unblinded self-reporting participants, and judged low risk of selection for certain dichotomous outcomes despite the absence of an analysis plan.
Por que isso importa
The RoB 2 tool and guidance are useful but resource-intensive and challenging to implement. Critical appraisal tools and reporting guidelines should detail risk of bias implementation. Improved guidance focusing on implementation could assist reviewers.
Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.
O estudo original
Risk-of-bias assessment using Cochrane's revised tool for randomized trials (RoB 2) was useful but challenging and resource-intensive: observations from a systematic review
Thomas Frederick Crocker, Natalie Lam, Magda Jordão, Caroline Brundle, Matthew Prescott, Anne Forster, Joie Ensor, John Gladman, Andrew Clegg
Descritores MeSH
- Research Report
- Humans
- Bias
- Randomized Controlled Trials as Topic
Veja também
Estudos relacionados
- Efeitos do treinamento muscular respiratório sobre a função respiratória, desfechos funcionais e complicações pulmonares em pacientes com AVC: revisão sistemática e metanálise de ensaios controlados randomizados
- Eficácia e segurança dos inibidores da PD-1/PD-L1 mais quimioterapia ± bevacizumab para o câncer do colo do útero recorrente ou metastático: uma revisão sistemática e metanálise de ensaios controlados randomizados
- O impacto da heterogeneidade intratumoral no desfecho e resistência à terapia no câncer de mama primário: uma revisão sistemática
- Os efeitos das intervenções de atividade física nas habilidades de autorregulação dos pré-escolares: revisão sistemática e metanálise de ensaios controlados randomizados